logo conference-reports

Kongressrapporter

Educational funding by logo MSD Oncology

WCLC 2019 – A non-invasive complementary biomarker improves the efficacy of lung cancer screening

Results of bioMILD trial indicate that longer LDCT screening intervals are feasible and safe in selected high-risk subjects
Tjenesten du prøver å få tilgang til er bare tilgjengelig for registrerte brukere. For å fortsette vennligst logg inn eller registrer deg for en gratis konto på Univadis